Harris Poll data indicate 92% of adults ≥45 years favor broad, Medicare-like insurance coverage for colorectal cancer blood tests, aligning public expectations with expanding FDA-cleared screening ...

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors who ...

Doctors should begin screening for heart disease and treating people for high cholesterol levels even younger than before, according to new recommendations from major medical organizations. While ...

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence uptake among guideline-eligible, average-risk adults starting at age 45.

The American Heart Association and American College of Cardiology released updated cholesterol guidelines that expand how cardiovascular risk is assessed. The new guidance recommends three additional ...

Abstract: Outlier screening is a popular approach for testing automotive products. In practice, developing an outlier model can be subjective, making justification of the model challenging. In this ...

Anne Jones, who is 51, is used to solving any problem that comes her way. She grew up on a farm in southeast Nebraska, where the humid summers and long, harsh winters made farming difficult. Jones was ...

Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the American Cancer Society, colorectal cancer is the third-leading cause of ...

SALT LAKE CITY — New parents may cringe thinking about the heel pricks routinely done after a baby is born and then again two weeks later, but the required screening saves lives. "I have had cases ...

A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in late-stage ...

The stock slid 47%, to $54.20, in after-hours trading. Through market close, share have surged 93% in the past year. The healthcare company said Thursday the test failed to meet the trial's target of ...